These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8007941

  • 41. Addition of dextran sulfate to blood cardioplegia attenuates reperfusion injury in a porcine model of cardiopulmonary bypass.
    Banz Y, Rieben R, Zobrist C, Meier P, Shaw S, Lanz J, Carrel T, Berdat P.
    Eur J Cardiothorac Surg; 2008 Sep; 34(3):653-60. PubMed ID: 18572413
    [Abstract] [Full Text] [Related]

  • 42. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M, Demircin M, Guvener M, Peker O, Yilmaz M.
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [Abstract] [Full Text] [Related]

  • 43. [Effect of complement 4 genetic polymorphism on complement activation during cardiopulmonary bypass in open heart surgery among children].
    Zhang S, Li Q, Yao S.
    Zhonghua Yi Xue Za Zhi; 2001 Aug 10; 81(15):918-20. PubMed ID: 11702666
    [Abstract] [Full Text] [Related]

  • 44. Release of granulocyte elastase and complement changes during hysterectomy.
    Wanscher M, Knudsen F, Antonsen S, Hansen SH.
    Scand J Clin Lab Invest; 1989 May 10; 49(3):255-8. PubMed ID: 2787048
    [Abstract] [Full Text] [Related]

  • 45. Effect of myocardial ischaemia-reperfusion on granulocyte elastase release.
    Ceriana P.
    Anaesth Intensive Care; 1992 May 10; 20(2):187-90. PubMed ID: 1595854
    [Abstract] [Full Text] [Related]

  • 46. Neutrophil lysosomal enzyme release and complement activation during cardiopulmonary bypass.
    Antonsen S, Brandslund I, Clemensen S, Søfeldt S, Madsen T, Alstrup P.
    Scand J Thorac Cardiovasc Surg; 1987 May 10; 21(1):47-52. PubMed ID: 3495878
    [Abstract] [Full Text] [Related]

  • 47. Neutrophil and macrophage activation and anaphylatoxin formation in orthotopic liver transplantation without the use of veno-venous bypass.
    Tomasdottir H, Bengtson JP, Bengtsson A.
    Acta Anaesthesiol Scand; 1996 Feb 10; 40(2):250-5. PubMed ID: 8848927
    [Abstract] [Full Text] [Related]

  • 48. [Clinical study of complement activation during cardiopulmonary bypass--analyses of complement activation pathway and transpulmonary leukosequestration].
    Miyamoto Y.
    Nihon Kyobu Geka Gakkai Zasshi; 1986 Dec 10; 34(12):2055-61. PubMed ID: 3559305
    [No Abstract] [Full Text] [Related]

  • 49. [Clinical significance of granulocyte elastase analysis in blood cell chemical tests].
    Sakurabayashi I, Itoh H.
    Nihon Rinsho; 1989 Dec 10; 48 Suppl():967-70. PubMed ID: 2695677
    [No Abstract] [Full Text] [Related]

  • 50. Complement and leukocytes during cardiopulmonary bypass: effects on plasma C3d and C5a, leukocyte count, release of granulocyte elastase and granulocyte chemotaxis.
    Knudsen F, Pedersen JO, Juhl O, Nielsen AH, Jersild C.
    J Cardiothorac Anesth; 1988 Apr 10; 2(2):164-70. PubMed ID: 17171907
    [Abstract] [Full Text] [Related]

  • 51. Effects of cardiopulmonary bypass on pulmonary leukostasis and complement activation.
    Howard RJ, Crain C, Franzini DA, Hood CI, Hugli TE.
    Arch Surg; 1988 Dec 10; 123(12):1496-501. PubMed ID: 3190431
    [Abstract] [Full Text] [Related]

  • 52. Monitoring of factor XII activity and granulocyte elastase release during cardiopulmonary bypass.
    Irvine L, Sundaram S, Courtney JM, Taggart DP, Wheatley DJ, Lowe GD.
    ASAIO Trans; 1991 Dec 10; 37(4):569-71. PubMed ID: 1768490
    [Abstract] [Full Text] [Related]

  • 53. Evidence of organ damage after cardiopulmonary bypass. The role of elastase and vasoactive mediators.
    Hashimoto K, Miyamoto H, Suzuki K, Horikoshi S, Matsui M, Arai T, Kurosawa H.
    J Thorac Cardiovasc Surg; 1992 Sep 10; 104(3):666-73. PubMed ID: 1355150
    [Abstract] [Full Text] [Related]

  • 54. [Time course of elastase alpha-1 protease inhibitor complex and white blood cell count in cardiac surgery with cardio-pulmonary bypass].
    Shimanuki K, Hamada O, Sakurabayashi I.
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Jan 10; 36(1):83-91. PubMed ID: 3385249
    [No Abstract] [Full Text] [Related]

  • 55. The calcium channel blocker nifedipine fails to inhibit leucocyte elastase release during cardiopulmonary bypass.
    Massaut J, Hennebert N, Tasiaux N, Demanet H.
    Acta Anaesthesiol Scand; 1993 Jan 10; 37(1):82-4. PubMed ID: 8424302
    [Abstract] [Full Text] [Related]

  • 56. On the kinetics of complement activation, leucopenia and granulocyte-elastase release induced by haemodialysis.
    Knudsen F, Nielsen AH, Pedersen JO, Jersild C.
    Scand J Clin Lab Invest; 1985 Dec 10; 45(8):759-66. PubMed ID: 3878572
    [Abstract] [Full Text] [Related]

  • 57. Effect of type of resection on plasma granulocyte elastase levels following surgery for non-small cell lung carcinoma.
    Martin P, Gebitekin C, Gupta NK, Tian Y, Ghaffari-Nejad M, Saunders NR, Walker DR.
    Eur J Cardiothorac Surg; 1994 Dec 10; 8(10):517-9. PubMed ID: 7826647
    [Abstract] [Full Text] [Related]

  • 58. Complement activation and lung permeability during cardiopulmonary bypass.
    Tennenberg SD, Clardy CW, Bailey WW, Solomkin JS.
    Ann Thorac Surg; 1990 Oct 10; 50(4):597-601. PubMed ID: 2222049
    [Abstract] [Full Text] [Related]

  • 59. Deleterious effects of complement activation on the lungs during extracorporeal circulation and its inhibition by FUT-175.
    Miyamoto Y, Matsuda H, Kawashima Y.
    J Biomater Appl; 1989 Jul 10; 4(1):56-68. PubMed ID: 2664117
    [Abstract] [Full Text] [Related]

  • 60. Plasma elastase concentrations and pulmonary function after cardiopulmonary bypass.
    Mair P, Mair J, Seibt I, Furtwaengler W, Balogh D, Puschendorf B.
    J Thorac Cardiovasc Surg; 1994 Jul 10; 108(1):184-5. PubMed ID: 8028367
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.